Investigators conducted a prospective cohort study to examine the risk of incident hypertension in women with migraine.
In patients with chronic pain, comorbid hypertension may be mediated by reduced heart rate variability and spontaneous baroreflex sensitivity.
Findings from a recent study were unable to show a cause and effect relationship between headache and cerebrospinal fluid pressure in idiopathic intracranial hypertension, despite that headache is typically the first symptom.
Researchers found that marijuana use increases risk of hypertension-related death by three-fold, and marijuana use is linked to greater cardiovascular risks than cigarette smoking.
Most primary care physicians can't identify all 11 risk factors for prediabetes, and it's important to address gaps in knowledge.
The Dietary Approaches to Stop Hypertension (DASH) diet is effective for prevention of gout.
Dr Pamela Rist discusses her research in women with migraine and hypertension at the 2017 American Academy of Neurology Annual Meeting in Boston, MA. Scroll to below the video for a full text transcript of Dr Rist's interview.
The risk for developing hypertension was slightly higher in women with a history of migraine compared with women who do not have a history of the condition.
Having knee osteoarthritis may increase the likelihood of developing hypertension.
The anti-nociceptive effect of beta-adrenergic blockade is associated with decreased joint pain and reduced opioid requirements in patients with symptomatic large joint osteoarthritis and hypertension.
Increase expected to lead to fewer coronary heart disease events, stroke events, CVD-related deaths.
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Tools to Address the Opioid Crisis
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- Central Sensitization in Greater Trochanteric Pain Syndrome
- Pain Acceptance May Reduce Headache-Related Disability in Migraine
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds